In-Use Testing of Cleanroom Garments

News
Article
Pharmaceutical TechnologyPharmaceutical Technology, Regulatory Sourcebook, March 2022
Volume 2022 eBook
Issue 1
Pages: 24–26, 39

Testing cleanroom garments while in use and during daily cleanroom operations is vital for contamination control.

Warut/Stock.adobe.com – Testing cleanroom garments while in use and during daily cleanroom operations is vital for contamination control.

Warut/Stock.adobe.com

Contamination is a serious issue in cleanroom operations, and controlling contamination generated by human operators and their clothing is a major concern. People disperse large numbers of particles that vary in number from person to person and over time. Thus, cleanroom garments must be designed to protect the environment and the process by containing the particles generated by the person while not becoming a source of contamination. An important decision that faces the manager of any cleanroom is the selection of a cleanroom garment or garment system, according to Anne Marie Dixon-Heathman, principal, Cleanroom Management Associates. Following up on a presentation given by Dixon-Heathman at INTERPHEX 2021 on in-use testing of garments, Pharmaceutical Technology spoke to Dixon-Heathman for further insight.

Read this article in Pharmaceutical Technology’s March 2022 Quality and Regulatory Sourcebook eBook.

About the author

Feliza Mirasol is the science editor for Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook, March 2022
March 2022
Pages: 24–26, 39

Citation

When referring to this article, please cite it as F. Mirasol, “In-Use Testing of Cleanroom Garments," Pharmaceutical Technology Quality and Regulatory Sourcebook eBook (March 2022).

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.